Introduction
The central nervous system and the immune system are closely interrelated. Stress and psychiatric illness have previously been associated with immune dysregulation (Calabrese et al. 1987 ). We reported earlier that patients with major depression manifested a reduction in mitogeninduced lymphocyte proliferation, a correlate of cellular immune function (Kronfol et al. 1983 ). These findings were later confirmed by other investigators (Schleifer et al. 1984) . We now report our preliminary results on Natural-Killer (NK) cell activity, a more specific parameter of immune function directed against tumor-or virus-infected cells, in 12 drug-free patients diagnosed with major depressive disorder and 12 age-and sex-matched normal controls.
Subjects and Methods

S&ejects
There were 12 depressed patients, 5 men. 7 women (mean -+ SD age 36.8 2 9.3). All patients were evaluated at the Department of Psy- (Spitzer et al. 1977) . The RDC diagnosis was confirmed by a structured interview conducted by a trained research nurse using the Schedule for Affective Disorders and Schizophrenia (SADS) (Spitzer and Endicott 1975) . At the time of the study? 10 patients were hospitalized and 2 were ambulatory. They all met DSM-III and RDC criteria for major depressive disorder and had a score of 2 1.5 on the 17-item Hamilton Depression Rating Scale, HDRS (Hamilton 1960) . All patients were also free of drugs known to interfere with immune regulation, and free of psychoactive drugs for at least 2 weeks prior to immune evaluation. In fact, only 3 patients were receiving psychotropic medications (tricyclic antidepressants and/or neuroleptics) 2 weeks prior to the immunological assessment. The mean 2 SD score on the HDRS was 19.5 + 4.8. The mean t SD score on the Carroll Depression Rating Scale (CDRS), a self-rating scale for depression (Carroll et al. 1981 ) was 29.0 -+ 9.1.
The normal control group consisted of 12 healthy volunteers, 5 men, 7 women (mean i SD age 36.5 ? 9.1), who were age and sex matched with the depressed patients. They were recruited in response to ads on the campus of the University of Michigan. Each control subject was interviewed with the SADS-Life Ver-
Brief Reports sion (SADS-L), and subjects with a history of psychiatric illness were excluded. Other exclusion criteria were history of medical illness or drugs known to affect the immune system. The mean HDRS score was 0.6 ? 0.9. The mean CDRS was 2.1 ? 2.5.
Comparisons between the depressed patients and the normal controls revealed no significant age or sex differences between the groups. There were, however, highly significant differences in both the HDRS (t = 15.8; p < 0.00001) and the CDRS (t = 7.6;~ < 0.0001) scores between the two groups.
Methods
Blood samples from each patient and his/her age-and-sex-matched normal control were drawn separately in heparinized tubes on the same day between 8:00 and 9:00 AM. Blood was diluted with phosphate-buffered saline (PBS pH 7.3) and centrifuged at 400 g for 30 min over a cushion of Ficoll-Hypaque solution. The mononuclear cell band was harvested, washed, and resuspended in RPM1 1640 medium containing 25 mM Hepes buffer supplemented with 10% heatinactivated fetal calf serum (Gibco, Grand Island, NY), 80 pg/ml gentamicin (Scherring Corp., Kenilworth, NJ), and 300 pg of fresh glutamine/ml (complete medium). Mononuclear cells were depleted of adherentimonocytes by chromatography on a column of Sephadex G-10 beads (Pharmacia Fine Chemicals, Piscataway, N. J .) equilibrated in the same medium. The cell recovery was >70% of the total input, and monocyte contamination as indicated by nonspecific esterase staining was ~2%. NK activity was then measured in a direct "Cr release assay as described previously (Nair and Schwartz 1984) . The human erythroleukemia cell line K562 was used as targets for NK cells. Four different effectortarget (E:T) cell ratios were used: 50: 1, 2S:l: 12.5:1, and 6.25:1. All samples were run in triplicate. Percent cytotoxicity * SD was then calculated for both patients and controls for each of the four different E:T cell ratios. The spontaneous release for labeled K562 target cells was always less than 10% of the total labeling.
Statistical Analysis
Differences between patients and their matched controls were calculated for each E:T cell ratio using a paired t-test analysis. Differences between patients and controls were also analyzed using repeated measures analysis of variance (ANOVA). Results were considered statistically significant wherever p < 0.05, two-tailed.
Results Figure 1 shows mean 2 SD percent cytotoxicity of lymphocytes from depressed patients and their matched controls against K562 target cells. Depressed patients had lower percent cytotoxicity values than their matched controls for all E:T cell ratios used. These differences were statistically significant at E:T cell ratio 50: I (t = 2.97, n = 12, p < 0.02) and E:T cell ratio 25: 1 (t = 3.1, n = 12, p < 0.02). A decreased cytotoxicity was also demonstrated at the lowest E:T cell ratios 12.5:l (t = 1.89 n = 12 p < 0.09) and 6.25:1 (t = 0.91 n = 12; NS), although these values were not significantly different from controls.
To assess the overall difference between the two groups, we then used repeated measures ANOVA of percent cytotoxicity between the groups. We found a significant group effect (F = 4.92; df = 1; p < 0.05), a significant dose effect (F = 247.31; df = 3;p < 0.0001) and a significant group by dose interaction (F = 5.33; df = 3; p < 0.01).
Discussion
These results suggest that NK cell activity, a key component of the immune response. is decreased in patients suffering from a major depressive episode. NK activity, like other defense mechanisms, can be affected by several clinical factors, including age, gender, nutritional status, diurnal variation, medical illness, and drugs. Patients and controls did not significantly differ in either age or gender distribution. Similarly, there were no significant differences in their respective mean body weights (73.0 t 18.5 kg for depressed patients, 65.3 2 10.9 kg for nor- ma1 controls; t = 1.6; NS). All blood samples were drawn at the same time of the day, and assays were run simultaneously on fresh blood samples from depressed patients and their matched controls. Patients were excluded if they met criteria for psychiatric disorders other than major depression. Normal controls had no evidence of psychiatric illness. Both patients and controls were physically healthy and free of drugs known to affect immune regulation, including psychoactive drugs.
A reduction in NK activity may represent an important feature of immunoregulation in patients with depressive illness. It should, however, be noted that this finding is not universally seen in patients with major depression. In the present study, only 7 of the 12 patients under investigation had significantly lower NK activity (by paired t-test analysis) than their matched controls. The other 5 patients did not differ significantly from their matched controls. In no instance did any depressed patient show a significantly higher NK activity than his/her matched control. Clinical and neuroendocrine factors that distinguish depressed patients with impaired NK activity from those with normal NK activity are presently under investigation.
More work is needed to clarify the relation among clinical, neuroendocrine, and immune phenomena in patients with depressive illness.
